Sfoglia per AUTORE
FREEDMAN MS
Collezione AOU San Luigi di Orbassano
Items : 2
Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years. in Multiple sclerosis journal - experimental, translational and clinical / Mult Scler J Exp Transl Clin. 2020 Dec 18;6(4):2055217320972137. doi: 10.1177/2055217320972137. eCol
2020
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Firmino I; Cavalier SJ; Freedman MS; Bertolotto A; Boster A; Horáková D; Jacobs AK; Thangavelu K; Daizadeh N; Poole EM; Baker DP; Margolin DH; Ziemssen T;
Neurofilament ELISA validation in Journal of Immunological Methods
2010
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Petzold A; Altintas A; Andreoni L; Bartos A; Berthele A; Blankenstein MA; Buee L; Castellazzi M; Cepok S; Comabella M; Constantinescu CS; Deisenhammer F; Deniz G; Erten G; Espiño M; Fainardi E; Franciotta D; Freedman MS; Giedraitis V; Gilhus NE; Giovannoni G; Glabinski A; Grieb P; Hartung H-P; Hemmer B; Herukka S-K; Hintzen R; Ingelsson M; Jackson S; et alii...